Addison's Disease News and Research

RSS
Addison's disease is an endocrine or hormonal disorder that occurs in all age groups and afflicts men and women equally. The disease is characterized by weight loss, muscle weakness, fatigue, low blood pressure, and sometimes darkening of the skin in both exposed and nonexposed parts of the body. Addison's disease occurs when the adrenal glands do not produce enough of the hormone cortisol and, in some cases, the hormone aldosterone. The disease is also called adrenal insufficiency, or hypocortisolism.
Penn State scientists develop citrate-based fluorescent sensor for diagnosis of cystic fibrosis

Penn State scientists develop citrate-based fluorescent sensor for diagnosis of cystic fibrosis

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Medicines that mimic body's natural systems can prevent debilitating side effects

Medicines that mimic body's natural systems can prevent debilitating side effects

Dr. Todd Darmody honored with 2012 Compassionate Doctor Certification

Dr. Todd Darmody honored with 2012 Compassionate Doctor Certification

Mallinckrodt receives FDA approval for 32 mg tablet strength of EXALGO

Mallinckrodt receives FDA approval for 32 mg tablet strength of EXALGO

Psoriasis link with autoimmune diseases underscored

Psoriasis link with autoimmune diseases underscored

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

AARDA hopes to educate public on autoimmune diseases during March

AARDA hopes to educate public on autoimmune diseases during March

AddisonsDisease.Net celebrates ten years of service

AddisonsDisease.Net celebrates ten years of service

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

Cortisol hormone controls bile acid recycling process

Cortisol hormone controls bile acid recycling process

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Addison's patients with low cortisol levels more likely to get infections

Addison's patients with low cortisol levels more likely to get infections

Covidien launches EXALGO Extended-Release Tablets in the US

Covidien launches EXALGO Extended-Release Tablets in the US

Patients with chronic conditions need support to re-enter employment

Patients with chronic conditions need support to re-enter employment

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

Vitiligo gene linked to other autoimmune diseases

Vitiligo gene linked to other autoimmune diseases

Researchers discover vitiligo gene

Researchers discover vitiligo gene